Medline (MDLN) Accumulated Expenses (2024 - 2026)

Medline (MDLN) has 3 years of Accumulated Expenses data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Accumulated Expenses changed N/A year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (changed N/A YoY) and the FY2025 annual result came in at $1.5 billion, down 2.75% from the prior year.
• Accumulated Expenses advanced to $1.5 billion in Q1 2026 per MDLN's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.5 billion in Q1 2026 and bottomed at $1.5 billion in Q4 2025.
• The 3-year median for Accumulated Expenses is $1.5 billion (2024), against an average of $1.5 billion.
• Peak annual rise in Accumulated Expenses reached 2.75% in 2025, while the deepest fall reached 2.75% in 2025.
• Tracing MDLN's Accumulated Expenses over 3 years: stood at $1.5 billion in 2024, then retreated by 2.75% to $1.5 billion in 2025, then advanced by 5.17% to $1.5 billion in 2026.
• Per Business Quant, the three latest MDLN Accumulated Expenses figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q4 2024).

Peer Comparison